Sodium spirulan as a potent inhibitor of arterial smooth muscle cell proliferation in vitro

Life Sciences

Volumn 74, Issue 19, 2004, Pages 2431-2439

  Kaji, Toshiyuki ^a   Okabe, Maiko ^a   Shimada, Satomi ^a   Yamamoto, Chika ^a   Fujiwara, Yasuyuki ^a   Lee, Jung Bum ^b   Hayashi, Toshimitsu ^b  

^a HOKURIKU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Atherosclerosis; Polysaccharide; Smooth muscle cell; Sodium spirulan; Vascular

Indexed keywords

CALCIUM ION; CHONDROITIN SULFATE; DERMATAN SULFATE; DEXTRAN SULFATE; FIBRINOLYTIC AGENT; HEPARAN SULFATE; HEPARIN; HYALURONIC ACID; POLYSACCHARIDE SULFATE; SODIUM ION; SODIUM SPIRULAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DAMAGE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DEPOLYMERIZATION; DRUG ACTIVITY; DRUG EFFECT; FIBRINOLYSIS; GROWTH INHIBITION; NONHUMAN; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIES; CATTLE; CELL COUNT; CELL DIVISION; CELLS, CULTURED; HEPARIN; L-LACTATE DEHYDROGENASE; MOLECULAR WEIGHT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POLYSACCHARIDES; SULFATES;

ALGAE; BOVINAE; CHLOROPHYTA; CYANOBACTERIA; SPIRULINA; SPIRULINA PLATENSIS;

EID: 1442348373     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.09.061     Document Type: Article

References (33)

1. Benezra M., Ishai-Michaeli R., Ben-Sasson S.A., Vlodavsky I. Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity. Journal of Cellular Physiology. 192:2002;276-285.
2. Benitz W.E., Lessler D.S., Coulson J.D., Bernfield M. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor. Journal of Cellular Physiology. 127:1986;1-7.
3. Burke J.M., Ross R. Synthesis of connective tissue macromolecules by smooth muscle. International Reviews of Connective Tissue Research. 8:1979;119-157.
4. Castellot J.J. Jr., Beeler D.L., Rosenberg R.D., Karnovsky M.J. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. Journal of Cellular Physiology. 120:1984;315-320.
5. Casu B. Structure of heparin and heparin fragments. Annuals of the New York Academy of Sciences. 556:1989;1-17.
6. Chan P., Mill S., Mulloy B., Kakkar V., Demoliou-Mason C. Heparin inhibition of human vascular smooth muscle cell hyperplasia. International Angiology. 11:1992;261-267.
7. Clowes A.W., Clowes M.M. Regulation of smooth muscle proliferation by heparin in vitro and in vivo. International Angiology. 6:1987;45-51.
8. Ettenson D.S., Koo E.W., Januzzi J.L., Edelman E.R. Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth. Journal of Cellular Physiology. 184:2000;93-100.
9. Garg H.G., Joseph P.A., Thompson B.T., Hales C.A., Toida T., Imanari T., Capila I., Linhardt R.J. Effect of fully sulfated glycosaminoglycans on pulmonary artery smooth muscle cell proliferation. Archives of Biochemistry and Biophysics. 371:1999;228-233.
10. Giraux J.L., Matou S., Bros A., Tapon-Bretaudiere J., Letourneur D., Fischer A.M. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin. European Journal of Cell Biology. 77:1998;352-359.
11. Hayakawa Y., Hayashi T., Hayashi K., Hayashi T., Ozawa T., Niiya K., Sakuragawa N. Heparin cofactor II-dependent antithrombin activity of calcium spirulan. Blood Coagulation and Fibrinolysis. 7:1996;554-560.
12. Hayakawa Y., Hayashi T., Hayashi K., Ozawa T., Niiya K., Sakuragawa N. Calcium spirulan as an inducer of tissue-type plasminogen activator in human fetal lung fibroblasts. Biochimica et Biophysica Acta. 1355:1997;241-247.
13. Hayakawa Y., Hayashi T., Lee J.B., Ozawa T., Sakuragawa N. Activation of heparin cofactor II by calcium spirulan. Journal of Biological Chemistry. 275:2000;11379-11382.
14. Hayashi K., Hayashi T., Morita N., Kojima I. An extract from Spirulina platensis is a selective inhibitor of herpes simplex virus type 1 penetration into HeLa cells. Phytotherapy Research. 7:1993;76-80.
15. Hayashi T., Hayashi K., Maeda M., Kojima I. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. Journal of Natural Products. 59:1996;83-87.
16. Hayashi K., Hayashi T., Kojima I. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities. AIDS Research and Human Retroviruses. 12:1996;1463-1471.
17. Hoover R.L., Rosenberg R., Haering W., Karnovsky M.J. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circulation Research. 47:1980;578-583.
18. Kaji T., Fujiwara Y., Hamada C., Yamamoto C., Shimada S., Lee J.B., Hayashi T. Inhibition of cultured bovine aortic endothelial cell proliferation by sodium spirulan, a new sulfated polysaccharide isolated from Spirulina platensis. Planta Medica. 68:2002;505-509.
19. Kaji T., Fujiwara Y., Inomata Y., Hamada C., Yamamoto C., Shimada S., Lee J.B., Hayashi T. Repair of wounded monolayers of cultured bovine aortic endothelial cells is inhibited by calcium spirulan, a novel sulfated polysaccharide isolated from Spirulina platensis. Life Sciences. 70:2002;1841-1848.
20. Kaji T., Shimada S., Yamamoto C., Fujiwara Y., Lee J.B., Hayashi T. Inhibition of the association of proteoglycans with cultured vascular endothelial cell layers by calcium and sodium spirulan. Journal of Health Science. 48:2002;250-255.
21. Kissane J.M., Robins E. The fluorometric measurement of deoxyribonucleic acid in animal tissue with special reference to the central nervous system. Journal of Biological Chemistry. 233:1958;184-188.
22. Lee J.B., Hayashi T., Hayashi K., Sankawa U., Maeda M., Nemoto T., Nakanishi H. Further purification and structural analysis of calcium spirulan from Spirulina platensis. Journal of Natural Products. 61:1998;1101-1104.
23. Lee J.B., Hayashi T., Hayashi K., Sankawa U. Structural analysis of calcium spirulan (Ca-SP)-derived oligosaccharides using electrospray ionization mass spectrometry. Journal of Natural Products. 63:2000;136-138.
24. Lee J.B., Srisomporn P., Hayashi K., Tanaka T., Sankawa U., Hayashi T. Effects of structural modification of calcium spirulan, a sulfated polysaccharide from Spirulina platensis, on antiviral activity. Chemical and Pharmaceutical Bulletin. 49:2001;108-110.
25. Nagasawa K., Inoue Y., Tokuyaku T. An improved method for the preparation of chondroitin by solvolytic desulfation of chondroitin sulfates. Journal of Biochemistry (Tokyo). 86:1979;1323-1329.
26. 3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis. British Journal of Pharmacology. 127:1999;361-368.
27. Paul R., Herbert J.M., Maffrand J.P., Lansen J., Modat G., Pereillo J.M., Gordon J.L. Inhibition of vascular smooth muscle cell proliferation in culture by pentosan polysulphate and related compounds. Thrombosis Research. 46:1987;793-801.
28. Robbie L.A., Booth N.A., Brown A.J., Bennett B. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arteriosclerosis, Thrombosis and Vascular Biology. 16:1996;539-545.
29. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London). 362:1993;801-809.
30. Schneiderman J., Sawdey M.S., Keeton M.R., Bordin G.M., Bernstein E.F., Dilley R.B., Loskutoff D.J. Increased type 1 plasminogen activator inhibitor gene expression in human atherosclerotic arteries. Proceedings of the National Academy of Science of the United States of America. 89:1992;6998-7002.
31. Vischer P., Buddecke E. Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism. European Journal of Cell Biology. 56:1991;407-414.
32. Wight T.N. Proteoglycans in pathological conditions: atherosclerosis. Federation Proceedings. 44:1985;381-385.
33. Yamamoto C., Nakamura A., Shimada S., Kaji T., Lee J.B., Hayashi T. Differential effects of sodium spirulan on the secretion of fibrinolytic proteins from vascular endothelial cells: an enhancement of plasminogen activator activity. Journal of Health Science. 49:2003;405-409.